Literature DB >> 18559847

Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes.

Pavitra Chakravarty1, Radu Marches, Neil S Zimmerman, Austin D-E Swafford, Pooja Bajaj, Inga H Musselman, Paul Pantano, Rockford K Draper, Ellen S Vitetta.   

Abstract

Single-walled carbon nanotubes (CNTs) emit heat when they absorb energy from near-infrared (NIR) light. Tissue is relatively transparent to NIR, which suggests that targeting CNTs to tumor cells, followed by noninvasive exposure to NIR light, will ablate tumors within the range of NIR. In this study, we demonstrate the specific binding of antibody-coupled CNTs to tumor cells in vitro, followed by their highly specific ablation with NIR light. Biotinylated polar lipids were used to prepare stable, biocompatible, noncytotoxic CNT dispersions that were then attached to one of two different neutralite avidin-derivatized mAbs directed against either human CD22 or CD25. CD22(+)CD25(-) Daudi cells bound only CNTs coupled to the anti-CD22 mAb; CD22(-)CD25(+) activated peripheral blood mononuclear cells bound only to the CNTs coupled to the anti-CD25 mAb. Most importantly, only the specifically targeted cells were killed after exposure to NIR light.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18559847      PMCID: PMC2438394          DOI: 10.1073/pnas.0803557105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Preparation and characterization of individual peptide-wrapped single-walled carbon nanotubes.

Authors:  Vasiliki Zorbas; Alfonso Ortiz-Acevedo; Alan B Dalton; Mario Miki Yoshida; Gregg R Dieckmann; Rockford K Draper; Ray H Baughman; Miguel Jose-Yacaman; Inga H Musselman
Journal:  J Am Chem Soc       Date:  2004-06-16       Impact factor: 15.419

2.  Radioimmunotherapy of non-Hodgkin's lymphoma: a critical appraisal.

Authors:  Robert M Sharkey; Jack Burton; David M Goldenberg
Journal:  Expert Rev Clin Immunol       Date:  2005-05       Impact factor: 4.473

3.  Immunotargeted nanoshells for integrated cancer imaging and therapy.

Authors:  Christopher Loo; Amanda Lowery; Naomi Halas; Jennifer West; Rebekah Drezek
Journal:  Nano Lett       Date:  2005-04       Impact factor: 11.189

4.  Amphiphilic helical peptide enhances the uptake of single-walled carbon nanotubes by living cells.

Authors:  Shook-Fong Chin; Ray H Baughman; Alan B Dalton; Gregg R Dieckmann; Rockford K Draper; Carole Mikoryak; Inga H Musselman; Vasiliki Z Poenitzsch; Hui Xie; Paul Pantano
Journal:  Exp Biol Med (Maywood)       Date:  2007-10

5.  Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction.

Authors:  Nadine Wong Shi Kam; Michael O'Connell; Jeffrey A Wisdom; Hongjie Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

6.  Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.

Authors:  P F Bross; J Beitz; G Chen; X H Chen; E Duffy; L Kieffer; S Roy; R Sridhara; A Rahman; G Williams; R Pazdur
Journal:  Clin Cancer Res       Date:  2001-06       Impact factor: 12.531

Review 7.  Hyperthermia in oncology.

Authors:  M H Falk; R D Issels
Journal:  Int J Hyperthermia       Date:  2001 Jan-Feb       Impact factor: 3.914

8.  A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

Authors:  A Engert; V Diehl; R Schnell; A Radszuhn; M T Hatwig; S Drillich; G Schön; H Bohlen; H Tesch; M L Hansmann; S Barth; J Schindler; V Ghetie; J Uhr; E Vitetta
Journal:  Blood       Date:  1997-01-15       Impact factor: 22.113

9.  A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Authors:  Roland Schnell; Oliver Staak; Peter Borchmann; Christine Schwartz; Bärbel Matthey; Hinrich Hansen; John Schindler; Victor Ghetie; Ellen S Vitetta; Volker Diehl; Andreas Engert
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

10.  Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes.

Authors:  Michael R McDevitt; Debjit Chattopadhyay; Barry J Kappel; Jaspreet Singh Jaggi; Scott R Schiffman; Christophe Antczak; Jon T Njardarson; Renier Brentjens; David A Scheinberg
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 11.082

View more
  58 in total

Review 1.  Functionalized carbon nanotubes for potential medicinal applications.

Authors:  Yi Zhang; Yuhong Bai; Bing Yan
Journal:  Drug Discov Today       Date:  2010-05-06       Impact factor: 7.851

2.  Carbon Nanotubes in Biology and Medicine: In vitro and in vivo Detection, Imaging and Drug Delivery.

Authors:  Zhuang Liu; Scott Tabakman; Kevin Welsher; Hongjie Dai
Journal:  Nano Res       Date:  2009-02-01       Impact factor: 8.897

Review 3.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

4.  The impact of subcellular location on the near infrared-mediated thermal ablation of cells by targeted carbon nanotubes.

Authors:  Vasanth S Murali; Ruhung Wang; Carole A Mikoryak; Paul Pantano; Rockford K Draper
Journal:  Nanotechnology       Date:  2016-09-15       Impact factor: 3.874

5.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

Review 6.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

7.  Measurement of mass-based carbon nanotube penetration through filtering facepiece respirator filtering media.

Authors:  Evanly Vo; Ziqing Zhuang; Eileen Birch; Qi Zhao; Matthew Horvatin; Yuewei Liu
Journal:  Ann Occup Hyg       Date:  2014-05-06

8.  Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor?

Authors:  John Liu; Liu Yang; Anton J Hopfinger
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

9.  Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells.

Authors:  Yan Xiao; Xiugong Gao; Oleh Taratula; Stephen Treado; Aaron Urbas; R David Holbrook; Richard E Cavicchi; C Thomas Avedisian; Somenath Mitra; Ronak Savla; Paul D Wagner; Sudhir Srivastava; Huixin He
Journal:  BMC Cancer       Date:  2009-10-02       Impact factor: 4.430

10.  Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes.

Authors:  Supratim Ghosh; Samrat Dutta; Evan Gomes; David Carroll; Ralph D'Agostino; John Olson; Martin Guthold; William H Gmeiner
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.